AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medicus Pharma Ltd. Director's Dealing 2025

Dec 18, 2025

Director's Dealing

Opens in your device viewer

Issuer: Medicus Pharma Ltd. (MDCX)
CIK: 0001997296
Period of Report: 2025-12-16

Reporting Person: Ashton William (Director)

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-12-16	Stock Option (right to buy)	$1.80	A	25000	Acquired	2030-12-16	Common Shares (25000)	Direct

F1: The option was granted on December 16, 2025. The option is scheduled to vest quarterly in four equal installments over one year.